TGFB2 and pancreatic ductal adenocarcinoma: High TGFB2 methylation was notably associated with improved OS in pancreatic ductal adenocarcinoma (PDAC) patients, showing a hazard ratio (HR) of 0.53 (95% CI: 0.334–0.843; p = 0.007).